Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Revision: v3.5.0; removed related topics 'Multiple myeloma' and 'MedlinePlus Genetics' and the reference 'Revision: v3.4.3'.
    Difference
    0.2%
    Check dated 2026-03-21T08:43:24.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added related topics for Multiple myeloma and MedlinePlus Genetics on the study page to improve navigation and context.
    Difference
    0.2%
    Check dated 2026-03-13T22:31:25.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed the terms 'Multiple myeloma' and related topics (MedlinePlus Genetics) and the older Revision: v3.4.2.
    Difference
    0.2%
    Check dated 2026-03-06T18:36:15.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page lists revision v3.4.2, replacing v3.4.1, indicating a minor metadata update with no changes to trial data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:44:12.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0 on the page, a minor version update with no changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:16:44.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a topic and 'MedlinePlus Genetics' as a related topic to the study page.
    Difference
    0.2%
    Check dated 2026-01-29T21:19:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.